C

Compass Therapeutics Inc.
NASDAQ:CMPX

Watchlist Manager
Compass Therapeutics Inc.
NASDAQ:CMPX
Watchlist
Price: 5.24 USD 3.15% Market Closed
Market Cap: 932m USD

Wall Street
Price Targets

CMPX Price Targets Summary
Compass Therapeutics Inc.

Wall Street analysts forecast CMPX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CMPX is 12.55 USD with a low forecast of 7.07 USD and a high forecast of 31.5 USD.

Lowest
Price Target
7.07 USD
35% Upside
Average
Price Target
12.55 USD
140% Upside
Highest
Price Target
31.5 USD
501% Upside
Compass Therapeutics Inc. Competitors:
Price Targets
688363
Bloomage Biotechnology Corp Ltd
11% Upside
2616
CStone Pharmaceuticals
149% Upside
SNDX
Syndax Pharmaceuticals Inc
94% Upside
300142
Walvax Biotechnology Co Ltd
35% Downside
COYA
Coya Therapeutics Inc
181% Upside
ADOC
Adocia SA
136% Upside
AZT
Arcticzymes Technologies ASA
63% Upside
QTTB
Homology Medicines Inc
301% Upside

Revenue
Forecast

Revenue Estimate
Compass Therapeutics Inc.

The compound annual growth rate of Compass Therapeutics Inc.'s revenue for the next 4 years is 301%.

N/A
Past Growth
301%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Compass Therapeutics Inc.

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat

Net Income
Forecast

Net Income Estimate
Compass Therapeutics Inc.

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-37%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CMPX's stock price target?
Price Target
12.55 USD

According to Wall Street analysts, the average 1-year price target for CMPX is 12.55 USD with a low forecast of 7.07 USD and a high forecast of 31.5 USD.

What is Compass Therapeutics Inc.'s Revenue forecast?
Projected CAGR
301%

The compound annual growth rate of Compass Therapeutics Inc.'s revenue for the next 4 years is 301%.

Back to Top